Highest-materiality recent filing
Accuray fully repays $18M 3.75% Convertible Senior Notes upon maturity
Remaining $18M principal plus $337,500 interest repaid on June 1, 2026.
Accuray Q3 revenue down 7% to $104.8M; net loss $11.8M; withdraws FY2026 guidance
Net loss of $11.8M ($0.09 per share) vs $1.3M loss YoY; Adjusted EBITDA $3.8M vs $6.0M.
Accuray COO Leonel Peralta departs effective April 26, 2026; no disagreement cited
Leonel Peralta, SVP and Chief Operations Officer, resigned effective April 26, 2026.
Accuray amends Dedication Capital consulting pact; cuts fees 50%, vests 916K shares immediately
Cash compensation reduced 50%: Base fee $175K for Apr–Oct 2026, FY2026 incentive min $132.8K, Sep Q min $54.7K.
Accuray appoints Paul Miele as SVP and Chief Commercial Officer
Paul Miele appointed Chief Commercial Officer effective April 6, 2026.
Accuray CCO Sandeep Chalke to depart March 31; separation includes $459K lump sum, equity vesting
Sandeep Chalke, SVP & Chief Commercial Officer, leaves Accuray effective March 31, 2026.
Accuray posts Q2 FY2026 earnings presentation; no detailed figures in filing
Posted investor presentation for fiscal 2026 second quarter earnings call on Feb 17, 2026.
Accuray non-reliance on FY2025 and Q1 FY2026 financials over RPO footnote errors; no P&L impact
Audit committee concluded audited FY2025 10-K and interim 10-Qs for FY2025 and Q1 FY2026 should no longer be relied upon due to RPO disclosure errors.
Accuray receives Nasdaq deficiency notice for bid price below $1; 180-day cure period
Received Nasdaq notice on Feb 2, 2026 for non-compliance with $1 minimum bid price rule.
Accuray Q2 net loss $0.11 per share; revenue down 12%; launches $25M transformation plan
Total net revenue $102.2M, down 12% YoY; product revenue fell 26% to $45.0M, service revenue up 4% to $57.2M.
Accuray CCO Sandeep Chalke resigns effective March 31, 2026
Sandeep Chalke, SVP & Chief Commercial Officer, will resign effective March 31, 2026.
Accuray director Byron Scott to retire from board effective Dec 31, 2025
Byron C. Scott, Class II director, informed board of retirement effective Dec 31, 2025.
Workforce reduction of ~15% global headcount; total restructuring charges estimated at ~$11M, mostly cash.
Accuray shareholders approve 2026 equity plan, elect directors, ratify auditor
Approval of 2026 Equity Incentive Plan authorizes up to 3,896,000 new shares plus rollover from prior plan.
Accuray Q1 revenue down 7%, net loss widens to $21.7M; CEO replaced, restructuring initiated
Revenue $93.9M (-7% YoY); product revenue $37.2M (-23%); service revenue $56.8M (+7%).
Accuray appoints Steve La Neve as CEO; prelim Q1 rev $92.5-94M, adj EBITDA ~($4M)
Steve La Neve appointed President & CEO effective Oct 20, 2025; succeeds Suzanne Winter who retired.
Jesse Chew ceased employment as SVP, Chief Legal Officer and Corporate Secretary on Sept 19, 2025.
Accuray director Kill not standing for re-election; Chief Legal Officer Chew to resign Sept 19
Robert C. Kill, Class I director, will not stand for re-election at November 2025 annual meeting; continues until then.
Accuray Q4 revenue $127.5M (-5% YoY); full year net loss narrows to $1.6M
Q4 revenue $127.5M, down 5% YoY; product revenue $70.7M (-11%), service revenue $56.8M (+4%).
Accuray refinances debt: $150M term loan from TCW, exchanges $82M notes for stock & cash
Exchanged ~$82M of 3.75% convertible notes for 8.88M shares and ~$68.6M cash; $18M of notes remain outstanding.
Accuray Q3 revenue $113.2M (+12% YoY); FY revenue guidance cut to $452-460M on tariffs
Q3 net loss narrowed to $1.3M ($0.01/sh) from $6.3M ($0.06/sh) a year ago; adjusted EBITDA rose to $6.0M from $1.1M.
Accuray appoints Leonel Peralta COO with $450K base, $80K sign-on, $750K RSUs
Leonel Peralta named SVP, Chief Operations Officer effective Feb 3, 2025; previously VP Global Operations at Siemens Healthineers.
Accuray Q2 FY2025 revenue up 8% to $116.2M, net income $2.5M; raises FY guidance
Revenue $116.2M (+8% YoY); net income $2.5M ($0.03 EPS) vs loss $9.6M ($0.10 loss) prior year.
Accuray hires Leonel Peralta as SVP, Chief Operations Officer effective Feb 3, 2025
Peralta will lead worldwide manufacturing operations and supply chain, reporting to CEO Suzanne Winter.
Accuray SVP Global Operations Michael Hoge departing Jan 6, 2025; successor search initiated
Michael Hoge, SVP Global Operations, will leave Accuray effective January 6, 2025, by mutual agreement with no dispute.
Accuray shareholders approve equity plan increases; appoints new principal accounting officer
Stockholders approved amendment to 2016 Equity Incentive Plan, adding 5,000,000 shares to reserve.
Accuray reports Q1 FY2025 revenue $101.5M, net loss $4.0M; raises full-year guidance
Revenue $101.5M (down 2% YoY); service revenue grew to $53.2M (+5% YoY) offsetting product decline.
Accuray appoints Michael Murphy as VP, Corporate Controller, effective Oct 21
Michael Murphy, CPA, appointed VP, Corporate Controller, leading global accounting, tax, regulatory reporting, and risk management.
Accuray CEO Suzanne Winter returns from medical leave; Chalke resumes CCO role
Suzanne Winter resumed duties as President and CEO effective October 15, 2024.
Accuray amends credit pact; revolver cut to $20M, added liquidity covenant
Available revolving commitments reduced to no more than $20 million under Fourth Amendment.
Accuray CEO Suzanne Winter takes temporary medical leave; Sandeep Chalke named interim CEO
CEO Suzanne Winter taking temporary medical leave to treat a treatable form of cancer, effective September 3, 2024.
Accuray Q4 revenue up 13.5% to $134.3M; posts net income of $3.4M; FY25 guidance issued
Q4 revenue $134.3M (+13.5% YoY); GAAP net income $3.4M vs loss $2.6M; Adj EBITDA $10.1M vs $5.2M.
Accuray CFO Ali Pervaiz named interim principal accounting officer after CAO resigns
Gina Corradetti resigns as VP, Chief Accounting Officer, effective May 17, 2024.
Accuray Q3 revenue down 14% to $101.1M; net loss $6.3M vs prior income $0.6M
Net revenue $101.1M (-14% YoY); product $49.6M, service $51.5M.
Accuray Q2 revenue falls 7% to $107.2M, net loss widens; orders up 19%
GAAP net loss $9.6M ($0.10/sh) vs $1.9M loss a year ago; adjusted EBITDA $2.0M down from $8.5M.
At Nov 9, 2023 annual meeting, stockholders approved amendment to 2016 Equity Incentive Plan, increasing authorized shares by 5,000,000.
Accuray Q1 revenue $103.9M (+7.7% YoY), net loss narrows to $3M, reaffirms FY2024 outlook
Revenue $103.9M (+7.7% YoY); product rev $53.4M (+19.7%), service rev $50.5M (-2.7%).
Accuray cuts ~5.9% of workforce as part of margin expansion plan, expects $2.5M cost in Q2 FY2024
Workforce reduction of ~5.9% committed Sept 13; employees informed Oct 25.
Accuray presents long-term growth strategy at ASTRO 2023; no financial updates disclosed
Company presented management slides at ASTRO 2023 investor briefing on Oct 3, 2023.
Accuray adopts amended bylaws with federal forum selection clause for Securities Act claims
Board approved amended bylaws effective September 14, 2023, aligning with Delaware law.
Accuray Q4 revenue $118.3M (+7.5%); FY GAAP net loss $9.3M vs $5.3M prior year
Q4 net revenue $118.3M (+7.5% YoY); GAAP net loss $2.6M ($0.03/share) vs loss $3.5M prior year.
Accuray relocates corporate headquarters to Madison, Wisconsin
Effective July 31, 2023, headquarters moved to 1240 Deming Way, Madison, WI 53717-1954.
Accuray Q3 revenue $118.1M (+22.8% YoY), net income $0.6M, record 30 systems shipped
Record quarterly revenue $118.1M, up 22.8% YoY; constant currency revenue $122.1M (+27%).
Director Elizabeth Dávila to retire from Accuray board effective April 30, 2023
Elizabeth Dávila, a Class III director, will retire from the Board and all committees effective April 30, 2023.
Accuray says SVB exposure immaterial; cash under $250k FDIC limit
Cash at Silicon Valley Bank is below $250,000, fully within FDIC insurance coverage.
Accuray presents at Cowen conference; no material new disclosures in filing
Accuray presented at Cowen 43rd Annual Health Care Conference on March 6, 2023.
Accuray presents at BTIG conference; slides discuss long-term growth strategy
Presentation slides furnished as Exhibit 99.1 cover innovation-driven growth strategy.
Accuray Q2 fiscal 2023 revenue $114.8M, net loss $1.9M; reiterates full-year guidance
Net revenue of $114.8M, down 1.3% YoY; GAAP net loss $1.9M vs income $0.2M last year.
Accuray signs consulting agreement with departing CAO Palomba; new exec employment contracts
Former CAO Franco Palomba departed Jan 3, 2023; consulting agreement at $375/hr through Mar 10, 2023.
Accuray CAO Franco Palomba resigns; Gina Corradetti appointed effective Jan 3, 2023
Chief Accounting Officer Franco Palomba resigns effective Jan 3, 2023, for personal reasons; no disagreement with company.
Leonel Peralta, Senior Vice President, Chief Operations Officer of Accuray Incorporated (the “Company”), departed from the Company effective April 26, 2026.
On June 3, 2025, the Board appointed Steven F. Mayer to the Board as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, effective immediately prior to, and contingent upon, the effectiveness of the Financing Agreement.
The Board of Directors of Accuray Incorporated (the “Company”) appointed Leonel Peralta as the Company’s Senior Vice President, Chief Operations Officer, effective February 3, 2025.
On November 21, 2024, the Company’s Board of Directors appointed Michael Murphy, 45, as the Company’s principal accounting officer, effective December 2, 2024.
Sandeep Chalke, who served as the Company’s interim Chief Executive Officer, will continue to serve as the Company’s Senior Vice President, Chief Commercial Officer.
On October 15, 2024, Accuray Incorporated (the “Company”) announced that Suzanne Winter, the Company’s Chief Executive Officer and President, has returned from her medical leave of absence and reassumed her duties as the Company’s Chief Executive Officer and President, effective the same date.
On August 28, 2024, Suzanne Winter, President and Chief Executive Officer of Accuray Incorporated (the “Company”) informed the board of directors of the Company (the “Board”) that she is taking a temporary medical leave of absence, effective September 3, 2024.
On August 30, 2024, in connection with Ms. Winter’s leave of absence and effective September 3, 2024, the Board appointed Sandeep Chalke, the Company’s Chief Commercial Officer, as the Company’s interim Chief Executive Officer and interim principal executive officer.
On May 6, 2024, Gina Corradetti provided Accuray Incorporated (the “Company”) with notice of her intent to resign from her position as VP, Chief Accounting Officer and principal accounting officer, which resignation will be effective May 17, 2024, to pursue other opportunities.
On May 9, 2024, the Company’s Board of Directors appointed Ali Pervaiz, the Company’s Senior Vice President, Chief Financial Officer, to serve as the Company’s interim principal accounting officer, effective May 17, 2024 until a permanent successor is appointed.
On March 8, 2023, Elizabeth Dávila, a Class III director of Accuray Incorporated (the “Company”), informed the Company’s Board of Directors (the “Board”) that she will retire from the Board, including all committees of the Board on which she sits, effective April 30, 2023, to pursue other interests.
the Board of Directors (the “Board”) of the Company appointed Mr. Robert C. Kill as a Class I member of the Company’s Board in order to fill a vacancy on the Board.
Max materiality 0.85 · Median 0.55 · Most common event leadership